West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $146.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $62.6M | 42.8% |
| Business Acquisitions | $3.3M | 2.2% |
| Dividends Paid | $21.7M | 14.8% |
| Stock Repurchases | $2.1M | 1.4% |
| Other Financing | $10.2M | 7.0% |
| Working Capital | $8.0M | 5.5% |
| Other | $11.3M | 7.7% |
| Net Cash Flow | $27.1M | 18.5% |